Loading…

ENDATA · Copyright (c) 2026 Endata · Data: CEPII BACI (Etalab 2.0), Federal Reserve G.17, U.S. BLS, Eurostat, World Bank (CC BY 4.0), GLEIF, SEC EDGAR; announcements summarized from the linked sourcesProspects Companies Sectors Announcements Countries

HOME BRIEF PROSPECTS SECTORS ANNOUNCEMENTS COMPANIES COUNTRIES

>

INDUSTRIAL MARKET INTELLIGENCE

ANNOUNCEMENTSAll New facility Expansion Investment Acquisition Contract Closure

INDUSTRIAL MACHINERY273.5▲ +4.87%AUTOMATION AND ROBOTICS348.5▲ +10.05%PUMPS AND VALVES401.5▲ +2.64%MATERIAL HANDLING340.7▲ +3.73%FOOD PROCESSING EQUIPMENT394.8▲ +4.07%STEEL AND METAL PRODUCTS344.9▲ +29.04%SPECIALTY CHEMICALS256.3▲ +5.14%PLASTICS AND POLYMERS327.5▲ +5.94%PACKAGING506.1▲ +8.86%INDUSTRIAL TEXTILES185.9▲ +3.45%ELECTRICAL EQUIPMENT256.3▲ +8.77%SEMICONDUCTORS AND INDUSTRIAL ELECTRONICS75.3▲ +26.02%AUTOMOTIVE COMPONENTS134.7▲ +3.13%AEROSPACE COMPONENTS291.0▲ +2.38%MEDICAL DEVICES146.2▲ +4.99%CONSTRUCTION MATERIALS262.9▲ +4.08%HVAC AND INDUSTRIAL REFRIGERATION243.3▲ +5.55%POWER GENERATION EQUIPMENT289.6▲ +3.63%WATER TREATMENT EQUIPMENT152.1▲ +2.68%MINING EQUIPMENT462.3▲ +3.56%INDUSTRIAL MACHINERY273.5▲ +4.87%AUTOMATION AND ROBOTICS348.5▲ +10.05%PUMPS AND VALVES401.5▲ +2.64%MATERIAL HANDLING340.7▲ +3.73%FOOD PROCESSING EQUIPMENT394.8▲ +4.07%STEEL AND METAL PRODUCTS344.9▲ +29.04%SPECIALTY CHEMICALS256.3▲ +5.14%PLASTICS AND POLYMERS327.5▲ +5.94%PACKAGING506.1▲ +8.86%INDUSTRIAL TEXTILES185.9▲ +3.45%ELECTRICAL EQUIPMENT256.3▲ +8.77%SEMICONDUCTORS AND INDUSTRIAL ELECTRONICS75.3▲ +26.02%AUTOMOTIVE COMPONENTS134.7▲ +3.13%AEROSPACE COMPONENTS291.0▲ +2.38%MEDICAL DEVICES146.2▲ +4.99%CONSTRUCTION MATERIALS262.9▲ +4.08%HVAC AND INDUSTRIAL REFRIGERATION243.3▲ +5.55%POWER GENERATION EQUIPMENT289.6▲ +3.63%WATER TREATMENT EQUIPMENT152.1▲ +2.68%MINING EQUIPMENT462.3▲ +3.56%

Biofourmis acquires Biovotion and inks commercialization deal with Novartis · Endata

◂ Announcements

Medical Devicesworld trade 2024+5.1% 5Y CAGR

Nov 18, 2019ACQUISITIONZürich, Switzerland, Switzerland

Biofourmis acquires Biovotion and inks commercialization deal with Novartis

Biofourmis acquired Swiss wearable biosensor company Biovotion for cash and equity, including its Everion device and patents. Separately, Biofourmis partnered with Novartis for commercial rollout of a heart failure management platform using AI and the Everion sensor, starting in Asia.

Status

Completed

Productswearable biosensorsAI-based monitoring platformheart failure management platform

CompaniesNovartis partner Biofourmis acquirer Biovotion target

Sectors#Medical Devices

“The acquisition will include Biovotion's clinical grade-wearable technology Everion, as well as its entire portfolio and pipeline, team, clients, partners and patents.”mobihealthnews.com

1 source
mobihealthnews.comBiofourmis acquires Biovotion, inks commercialization deal with Novartis | MobiHealthNewsLaura LovettNov 18, 2019

Summarized from public sources; check the original articles before acting on it.

More from Novartis

Sep 1, 2020ACQUISITIONMarburg, Germany, Germany300 jobs
BioNTech to acquire Novartis GMP manufacturing site in Marburg, Germany
BioNTech acquirer Novartis target biontech.com
Oct 21, 2019CONTRACT
SomaLogic and Novartis sign ten-year proteomics agreement
Novartis customer SomaLogic supplier globenewswire.com
Jul 12, 2019ACQUISITION$390.0M
Recordati to acquire worldwide rights to Signifor and Osilodrostat from Novartis
Novartis target Recordati acquirer reuters.com
Feb 19, 2019EXPANSIONDurham, North Carolina, United States$60.0M200 jobsops Q3 2020
AveXis expands gene therapy manufacturing facility in North Carolina with additional $60M investment
AveXis Novartis investor fiercepharma.com
Dec 20, 2018ACQUISITIONUnited States$2.00B
Novartis completes $2B acquisition of Endocyte
Novartis acquirer Endocyte target uk.marketscreener.com
Aug 28, 2018NEW FACILITYStein, Switzerland$92.0M450 jobs
Novartis to build $92M cell and gene therapy plant in Stein, Switzerland
Novartis bioprocessintl.com

Similar announcements

Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com
Nov 5, 2026ACQUISITIONUnited States
Curewell Capital to acquire majority stake in ECA Medical
Curewell Capital acquirer ECA Medical target businesswire.com
Nov 5, 2026ACQUISITIONUnited States$538.0M
ZOLL Medical to acquire Itamar Medical for $538M
Asahi Kasei investor ZOLL Medical Corporation acquirer forpressrelease.com
Nov 4, 2026ACQUISITIONPlano, Texas, United States$2.25M
OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC FoxEyes target en.edaily.co.kr
Nov 3, 2026ACQUISITIONDeerfield, Illinois, United States
Vantive to divest majority of hemodialysis assets to Rockwell Medical
Vantive Rockwell Medical acquirer prnewswire.com
Nov 3, 2026ACQUISITIONMedolla, Italy, Italy$125.0M
Rockwell Medical to acquire Vantive's hemodialysis business for $400-450M annual revenue
Rockwell Medical acquirer Vantive target sec.gov nasdaq.com securities.io